This is especially relevant in NMIBC because BCG is known to enhance the antitumoral effect of T-cells and CD4- and CD8-positive cells are regarded to be essential for tumour elimination in NMIBC undergoing BCG treatment (16–18). The gene discussed is CD8A; the disease is neoplasm.